These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5308773)

  • 21. [Use of water-insoluble enzyme resins with polyanionic and polyamphoteric resin matrices for the isolation of protease inhibitors].
    Fritz H; Gebhardt M; Fink E; Schramm W; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 Feb; 350(2):129-38. PubMed ID: 5305002
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary report on the local treatment of joints with the protease-inhibitor Contrykal].
    Engler J
    Dtsch Gesundheitsw; 1969 Nov; 24(46):2195-6. PubMed ID: 5385553
    [No Abstract]   [Full Text] [Related]  

  • 23. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
    Hnatowich DJ; Qu T; Chang F; Ley AC; Ladner RC; Rusckowski M
    J Nucl Med; 1998 Jan; 39(1):56-64. PubMed ID: 9443739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of synthetic antifibrinolytic agents in body fluids and organs].
    Markwardt F; Klöcking HP; Richter M
    Pharmazie; 1967 Feb; 22(2):83-7. PubMed ID: 5602753
    [No Abstract]   [Full Text] [Related]  

  • 25. [The determination of natural protease inhibitors in biologic materials].
    Richter M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):130-5. PubMed ID: 4174650
    [No Abstract]   [Full Text] [Related]  

  • 26. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T; Buluk K
    Acta Physiol Pol; 1966; 17(4):569-80. PubMed ID: 6007876
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protease inhibitors and antifibrinolytic therapy].
    Manrique R
    Arq Bras Cardiol; 1984 Nov; 43(5):355-60. PubMed ID: 6242229
    [No Abstract]   [Full Text] [Related]  

  • 28. Autodisplay of the protease inhibitor aprotinin in Escherichia coli.
    Jose J; Zangen D
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1218-26. PubMed ID: 15979569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of deep venous thrombosis in the elderly: a higher D-dimer cut-off value is better?
    Aguilar C; Martinez A; Martinez A; Del Rio C; Vazquez M
    Haematologica; 2001 Oct; 86(10):E28. PubMed ID: 11602435
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation of aprotinin, a therapeutic protease inhibitor, into the thylakoid lumen of genetically engineered tobacco chloroplasts.
    Tissot G; Canard H; Nadai M; Martone A; Botterman J; Dubald M
    Plant Biotechnol J; 2008 Apr; 6(3):309-20. PubMed ID: 18266824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of a new fibrinolysis inhibitor by chromogenic substrates: the fast antiplasmin (author's transl)].
    Diaz-Cremades JM; Vicente JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(3):347-57. PubMed ID: 675457
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of a protease inhibitor "Aprotinin" on acute ischemic myocardium].
    Tanaka H; Okamura T; Suzuki T; Sunamori M; Suzuki A
    Rinsho Kyobu Geka; 1984 Sep; 4(5):544-9. PubMed ID: 6084298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Animal experimental studies on the effect of a protease inhibitor from the bovine lung].
    Markwardt F; Klöcking HP; Haustein KO; Perlewitz J
    Acta Biol Med Ger; 1966; 16(1):15-25. PubMed ID: 5974483
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation.
    Sperzel M; Huetter J
    J Thromb Haemost; 2007 Oct; 5(10):2113-8. PubMed ID: 17666018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone.
    Anderson NR; Nicholas J; Holland MR; Gama R
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):188-90. PubMed ID: 12662411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibitors of fibrinolysis in the human placenta. Histochemical study].
    Fornasari PM; Sora A; Bolis PF; Guaschino S
    Ann Ostet Ginecol Med Perinat; 1977; 98(2):104-7. PubMed ID: 855972
    [No Abstract]   [Full Text] [Related]  

  • 40. Aprotinin: 1 year on.
    Dietrich W
    Curr Opin Anaesthesiol; 2009 Feb; 22(1):121-7. PubMed ID: 19295302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.